
Podcast #525 · 14 Mar 2025
Principles to Practice: An HCC Tumor Board
- Medical Oncology
- Liver Transplant
- Y90 Radioembolization
- Immunotherapy
- Hepatocellular Carcinoma (HCC)
- Liver Resection
- Interventional Oncology (IO)
- Tumor Board
- Hepatobiliary Surgery
- Transarterial Chemoembolization (TACE)
- Transplant Surgery
- Interventional Radiology (IR)
- Hepatology
Do you ever wish you could be a fly on the wall at a tumor board meeting? In this episode of BackTable, we’re excited to give you an insider’s view of the real case discussions that take place during hepatocellular carcinoma (HCC) tumor boards. Host Dr. Zach Berman sits down with a multidisciplinary team, including Drs. Adam Burgoyne (medical oncologist), Heather Patton (hepatologist), Siddharth Padia (interventional radiologist), and Gabriel Schnickel (transplant and hepatobiliary surgeon).
This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific.
Timestamps
Resources
More about this episode
The team walks through a range of diverse HCC cases, reviewing patient histories, imaging, and treatment options. They cover eight cases in total, each featuring patients with varying treatment histories, comorbidities, liver function, and lesion characteristics. For the full educational experience, we recommend watching the video format on our YouTube channel.

